CHU Nimes — Nîmes

Public research footprint of CHU Nimes, compiled from the ClinicalTrials.gov public registry.

171

Registered studies

Active

Recruiting now

102

Completed

Stopped or withdrawn

Most-studied conditions

Urinary Bladder Neoplasms · Crohn's Disease · Episodic Migraine · Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome…

Recently updated registry entries

NCT04640623 — A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in… (Active Not Recruiting)
NCT05242484 — A Study of Combination Therapy With Guselkumab and Golimumab in Participants With… (Active Not Recruiting)
NCT07499232 — A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Nimes?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.